Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pharma Management Consulting ApS
APS
Active
Advertising protection
CVR 44806975
Øverødvej 47B, 2840
Holte
Other financial service activities, except insurance and pension funding n.e.c.
·
NACE 6499
Est. 2024 · 2 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Other financial service activities, except insurance and pension funding n.e.c.
/
Pharma Management Consulting ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
1M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2025
Income statement
DKK thousands
Item
2025
Gross profit
1.279
Staff expenses
-1.009
EBITDA
269
Depreciation & amort.
-0
EBIT
269
Net financials
-13
Profit before tax
257
Tax
56
Net profit
200
Balance sheet
DKK thousands
Item
2025
Total assets
404
Equity
240
Long-term debt
0
Short-term debt
164
Total debt
164
Financial ratios
5-year trend
EBITDA margin (of gross profit)
21.1%
This company
2025
2025
Equity ratio
59.4%
This company
38.2%
Market median
+55% vs market
2025
2025
Return on equity
83.4%
This company
18.4%
Market median
+353% vs market
2025
2025
Net profit margin (of gross profit)
15.7%
This company
2025
2025
Asset turnover (of gross profit)
3.16×
This company
2025
2025
Debt / equity
0.68×
This company
0.62×
Market median
+10% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-05-02 – 2025-06-30
View
PDF
More on Pharma Management Consulting ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
